Comparison of Two Different Insulin Dose Calculation Algorithms in Type 1 Diabetes

Sponsor
TC Erciyes University (Other)
Overall Status
Completed
CT.gov ID
NCT04131049
Collaborator
(none)
15
1
2
7
2.1

Study Details

Study Description

Brief Summary

The aim of this study is to compare the impact of carbohydrate counting (CC) method which is standard insulin dose calculation algorithm and food insulin index (FII) method which is a new algorithm on postprandial glucose following a high fat and a high protein meal in adolescent with type 1 diabetes. A randomized, single-blind and crossover trial included 14 adolescents aged 14-18 years with type 1 diabetes. All participants were sent to their homes for 4 consecutive days with a different glycemic index breakfast. The insulin doses of the meals were calculated according to CC and FII methods. Test breakfasts with different GIs and insulin requirements calculated with different algorithms are as follows: High GI calculated by CC (CHGI), low GI calculated by CC (CLGI), high GI calculated by FII (FHGI) and low GI calculated by FII (FLGI).

Condition or Disease Intervention/Treatment Phase
  • Other: High GI calculated by CC (CHGI)
  • Other: Low GI calculated by CC (CLGI)
  • Other: High GI calculated by FII (FHGI)
  • Other: Low GI calculated by FII (FLGI)
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Screening
Official Title:
Comparison of Carbohydrate Counting and Food Insulin Index Methods in the Determination of Insulin Doses for High- and Low-Glycemic Index Meals in Adolescents With Type 1 Diabetes
Actual Study Start Date :
Jun 24, 2019
Actual Primary Completion Date :
Nov 24, 2019
Actual Study Completion Date :
Jan 24, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Carbohydrate Counting

The insulin doses of the breakfasts were calculated according to carbohydrate counting.

Other: High GI calculated by CC (CHGI)
This test meal with high GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.

Other: Low GI calculated by CC (CLGI)
This test meal with low GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.

Experimental: Food Insulin Index

The insulin doses of the breakfasts were calculated according to food insulin index.

Other: High GI calculated by FII (FHGI)
This test meal with high GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.

Other: Low GI calculated by FII (FLGI)
This test meal with low GI were served as a breakfast after 8-hours fasting and participants were asked to consume the meal in full, within 20 min.

Outcome Measures

Primary Outcome Measures

  1. Postprandial glucose response by glucometer [Four hours postprandial period (from fasting to 240 minutes after the test breakfast)]

    Postprandial glucose response was quantified as incremental area under the curve (iAUC) (mg/dL x minutes), which was calculated according to the trapezoidal rule by using blood glucose values at time points 0, 30, 60, 90, 120, 150, 180, 210 and 240 minutes.

  2. Postprandial glucose response by continous glucose monitoring [Four hours postprandial period (from fasting to 240 minutes after the test breakfast)]

    Postprandial glucose response was quantified as incremental area under the curve (iAUC) (mg/dL x minutes), which was calculated according to the trapezoidal rule by using blood glucose values at time points 0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145, 150, 155, 160, 165, 170, 175, 180, 185, 190, 195, 200, 205, 210, 215, 220, 225, 230, 235 and 240 minutes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged between 14-18 years adolescents

  • Type 1 diabetes diagnosed for at least one year

  • Performing self-monitoring of blood glucose and doses of insulin at least four times daily

  • HbA1c ≤ 9.6% for the last three months

  • Negative fasting C-peptide (<0.1 nmol/L)

  • Total daily insulin use of ≥ 0.5 U/kg

  • World Health Organization BMI/age z-score of -1 to below 3

Exclusion Criteria:
  • Complications of diabetes or other medical conditions including celiac disease

  • Treatment with oral hypoglycaemic agents

  • Food allergies, intolerances, or eating disorder

  • Intestinal malabsorptions

  • Delayed gastric emptying

  • Viral or bacterial infection

  • Physical or mental disability

  • Clinical condition related to impaired digestive system such as cystic fibrosis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erciyes University Faculty of Health Sciences Kayseri Turkey 38039

Sponsors and Collaborators

  • TC Erciyes University

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Zeynep Caferoglu, PhD, Assistant Professor Doctor, TC Erciyes University
ClinicalTrials.gov Identifier:
NCT04131049
Other Study ID Numbers:
  • 8811
First Posted:
Oct 18, 2019
Last Update Posted:
Feb 9, 2021
Last Verified:
Feb 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zeynep Caferoglu, PhD, Assistant Professor Doctor, TC Erciyes University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2021